NZ213812A - Sulphonamides and pharmaceutical compositions - Google Patents

Sulphonamides and pharmaceutical compositions

Info

Publication number
NZ213812A
NZ213812A NZ213812A NZ21381285A NZ213812A NZ 213812 A NZ213812 A NZ 213812A NZ 213812 A NZ213812 A NZ 213812A NZ 21381285 A NZ21381285 A NZ 21381285A NZ 213812 A NZ213812 A NZ 213812A
Authority
NZ
New Zealand
Prior art keywords
sulphonamides
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
NZ213812A
Other languages
English (en)
Inventor
B B Molloy
M I Steinberg
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NZ213812A publication Critical patent/NZ213812A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NZ213812A 1984-10-15 1985-10-14 Sulphonamides and pharmaceutical compositions NZ213812A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/660,816 US4569801A (en) 1984-10-15 1984-10-15 Alkylsulfonamidophenylalkylamines

Publications (1)

Publication Number Publication Date
NZ213812A true NZ213812A (en) 1989-01-06

Family

ID=24651088

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ213812A NZ213812A (en) 1984-10-15 1985-10-14 Sulphonamides and pharmaceutical compositions

Country Status (18)

Country Link
US (1) US4569801A (enExample)
EP (1) EP0178874B1 (enExample)
JP (1) JPS6197256A (enExample)
KR (1) KR880001008B1 (enExample)
CN (1) CN1004133B (enExample)
AR (1) AR241528A1 (enExample)
AT (1) ATE41922T1 (enExample)
AU (1) AU586644B2 (enExample)
CA (1) CA1291165C (enExample)
DK (1) DK164450C (enExample)
ES (1) ES8609229A1 (enExample)
GR (1) GR852496B (enExample)
HU (1) HU195479B (enExample)
IL (1) IL76707A0 (enExample)
NZ (1) NZ213812A (enExample)
PT (1) PT81299B (enExample)
SU (1) SU1424730A3 (enExample)
ZA (1) ZA857871B (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5155268A (en) * 1984-05-04 1992-10-13 The Upjohn Company Antiarrhythmic N-aminoalkylene alkyl and aryl sulfonamides
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
GB8706662D0 (en) * 1987-03-20 1987-04-23 Pfizer Ltd Anti-arrhythmia agents
DE3732094A1 (de) * 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
US4906634A (en) * 1988-03-08 1990-03-06 Schering A.G. Novel N-[4-(aminosubstituted)phenyl]methanesulfonamides and their use as cardiovascular agents
US5238959A (en) * 1988-04-08 1993-08-24 Eli Lilly And Company 3-phenyloxy-3-phenyl propanamines
CA1337128C (en) * 1988-04-08 1995-09-26 David Wayne Robertson Propanamine derivatives
US5405997A (en) * 1989-07-25 1995-04-11 The Upjohn Company Antiarrhythmic methanesulfonamides
JPH10505829A (ja) * 1994-09-12 1998-06-09 ファルマシア・アンド・アップジョン・カンパニー 抗不整脈活性を有する４−（４−メタンスルホンアミドフェニル）ブチルアミン誘導体
US5874475A (en) * 1995-12-21 1999-02-23 Pharmacia & Upjohn Company Antiarrhythmic (S)-enantiomers of methanesulfonamides
US6012457A (en) * 1997-07-08 2000-01-11 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US5971983A (en) 1997-05-09 1999-10-26 The Regents Of The University Of California Tissue ablation device and method of use
US6024740A (en) 1997-07-08 2000-02-15 The Regents Of The University Of California Circumferential ablation device assembly
US6245064B1 (en) 1997-07-08 2001-06-12 Atrionix, Inc. Circumferential ablation device assembly
US6164283A (en) * 1997-07-08 2000-12-26 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US6514249B1 (en) 1997-07-08 2003-02-04 Atrionix, Inc. Positioning system and method for orienting an ablation element within a pulmonary vein ostium
US6652515B1 (en) 1997-07-08 2003-11-25 Atrionix, Inc. Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
US6966908B2 (en) 1997-07-08 2005-11-22 Atrionix, Inc. Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
US6869431B2 (en) 1997-07-08 2005-03-22 Atrionix, Inc. Medical device with sensor cooperating with expandable member
US6500174B1 (en) 1997-07-08 2002-12-31 Atrionix, Inc. Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member
US6997925B2 (en) * 1997-07-08 2006-02-14 Atrionx, Inc. Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
WO2000010557A1 (fr) * 1998-08-25 2000-03-02 Nippon Shinyaku Co.,Ltd. Preparations solides stabilisees
US6607502B1 (en) 1998-11-25 2003-08-19 Atrionix, Inc. Apparatus and method incorporating an ultrasound transducer onto a delivery member
US6758830B1 (en) 1999-05-11 2004-07-06 Atrionix, Inc. Catheter positioning system
EP2289448B1 (en) 1999-05-11 2013-03-13 Atrionix, Inc. Tissue ablation system including a balloon anchor wire
AU6321301A (en) * 2000-05-16 2001-11-26 Atrionix Inc Apparatus and method incorporating an ultrasound transducer onto a delivery member
AU6682401A (en) 2000-06-13 2001-12-24 Atrionix Inc Surgical ablation probe for forming a circumferential lesion
CA2391051C (en) 2000-09-08 2011-07-12 Atrionix, Inc. Medical device with sensor cooperating with expandable member
US6755822B2 (en) 2001-06-01 2004-06-29 Cryocor, Inc. Device and method for the creation of a circumferential cryogenic lesion in a pulmonary vein
US6932804B2 (en) 2003-01-21 2005-08-23 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
WO2003095016A1 (en) * 2002-05-08 2003-11-20 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
US20040106896A1 (en) * 2002-11-29 2004-06-03 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
US6786202B2 (en) * 2002-09-24 2004-09-07 Caterpillar Inc Hydraulic pump circuit
US7317950B2 (en) * 2002-11-16 2008-01-08 The Regents Of The University Of California Cardiac stimulation system with delivery of conductive agent
US7670335B2 (en) 2003-07-21 2010-03-02 Biosense Webster, Inc. Ablation device with spiral array ultrasound transducer
US7247269B2 (en) * 2003-07-21 2007-07-24 Biosense Webster, Inc. Method for making a spiral array ultrasound transducer
MXPA06007624A (es) * 2003-12-31 2007-01-30 Johnson & Johnson Montaje de dispositivo de ablacion circunferencial con dos miembros expansibles.
US8932208B2 (en) * 2005-05-26 2015-01-13 Maquet Cardiovascular Llc Apparatus and methods for performing minimally-invasive surgical procedures
US20060270900A1 (en) * 2005-05-26 2006-11-30 Chin Albert K Apparatus and methods for performing ablation
US20070185479A1 (en) * 2006-02-06 2007-08-09 Liming Lau Methods and devices for performing ablation and assessing efficacy thereof
US20070225697A1 (en) * 2006-03-23 2007-09-27 Ketan Shroff Apparatus and methods for cardiac ablation
US20080039879A1 (en) * 2006-08-09 2008-02-14 Chin Albert K Devices and methods for atrial appendage exclusion
US8728073B2 (en) 2006-10-10 2014-05-20 Biosense Webster, Inc. Multi-region staged inflation balloon
US8512387B2 (en) * 2007-09-07 2013-08-20 Robert S. Fishel Esophageal cooling system for ablation procedures associated with cardiac arrhythmias
WO2009045265A1 (en) 2007-10-05 2009-04-09 Maquet Cardiovascular, Llc Devices and methods for minimally-invasive surgical procedures
US20090209986A1 (en) * 2008-02-15 2009-08-20 Stewart Michael C Devices, Tools and Methods for Atrial Appendage Exclusion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR152F (enExample) * 1962-01-24
US3574741A (en) * 1969-04-14 1971-04-13 Mead Johnson & Co Sulfonamidophenalkylamines
HU173192B (hu) * 1973-08-13 1979-03-28 Fujisawa Pharmaceutical Co Sposob poluchenija novykh proizvodnykh fenilglicina
US4277501A (en) * 1977-12-19 1981-07-07 Eli Lilly And Company Para-nitrophenylalkylamines and pharmaceutical compositions
US4289787A (en) * 1977-12-19 1981-09-15 Eli Lilly And Company Quaternary ammonium antiarrhythmic drugs
CA1120058A (en) * 1978-07-03 1982-03-16 Jack Mills Phenethanolamines, formulations and potentiation of oncolytic drugs
US4336269A (en) * 1979-12-10 1982-06-22 Eli Lilly And Company Para-nitrophenylalkylamines
EP0164865B1 (en) * 1984-05-04 1988-12-21 The Upjohn Company N-(aminoalkylphenyl)sulfonamides their preparation and therapeutic use

Also Published As

Publication number Publication date
EP0178874A1 (en) 1986-04-23
AU586644B2 (en) 1989-07-20
EP0178874B1 (en) 1989-04-05
IL76707A0 (en) 1986-02-28
AU4855885A (en) 1986-04-24
CN1004133B (zh) 1989-05-10
KR860003210A (ko) 1986-05-21
ZA857871B (en) 1987-05-27
DK164450B (da) 1992-06-29
ES547840A0 (es) 1986-09-01
GR852496B (enExample) 1986-02-18
AR241528A1 (es) 1992-08-31
CA1291165C (en) 1991-10-22
JPS6197256A (ja) 1986-05-15
KR880001008B1 (ko) 1988-06-13
CN85107020A (zh) 1986-04-10
HU195479B (en) 1988-05-30
HUT38610A (en) 1986-06-30
PT81299B (pt) 1988-02-17
DK468185A (da) 1986-04-16
DK164450C (da) 1992-11-16
ATE41922T1 (de) 1989-04-15
US4569801A (en) 1986-02-11
PT81299A (en) 1985-11-01
SU1424730A3 (ru) 1988-09-15
ES8609229A1 (es) 1986-09-01
DK468185D0 (da) 1985-10-14

Similar Documents

Publication Publication Date Title
NZ211145A (en) 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
NZ212005A (en) Pyrrolobenzimidazoles and pharmaceutical compositions
IL74758A (en) Acyltripeptides and pharmaceutical compositions containing them
NZ222980A (en) 3-aryloxy-3-substituted propanamines and pharmaceutical compositions
NZ223096A (en) Peptidylaminodiols and pharmaceutical compositions
NZ212099A (en) Substituted arylhydroxamates and pharmaceutical compositions
IL82221A0 (en) Phenyl-piperazines and pharmaceutical compositions containing them
NZ218115A (en) Bicyclic sulphonamides and pharmaceutical compositions
NZ211031A (en) 6-substituted-4-dialkylaminotetrahindole derivatives and pharmaceutical compositions
NZ220020A (en) 1-hydroxy-2-pyridones and pharmaceutical composition
NZ226450A (en) Crystalline-1-carbacephalosporin and pharmaceutical compositions
IL74865A0 (en) 9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them
IL79376A0 (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
IL76188A (en) 3-aralkylidene-hydroxy-flavanone derivatives and pharmaceutical compositions containing them
NZ214821A (en) Spiro-dioxolanes, -dithiolanes and -oxothiolanes and pharmaceutical compositions
NZ209095A (en) Piperidinoquinazolines and pharmaceutical compositions
NZ210818A (en) 8-alpha-acylaminoergoline derivatives and pharmaceutical compositions
NZ212953A (en) 3-acyl-1-aminoalkyl-1h-indoles and pharmaceutical compositions thereof
NZ214088A (en) 1,3-diazoles and pharmaceutical compositions
GB2167414B (en) Flavolignan derivatives and pharmaceutical compositions containing them
NZ215070A (en) Imidazole-indoles and pharmaceutical compositions
NZ208244A (en) Phenyl-pyrazol-3-ones and pharmaceutical compositions
NZ213581A (en) Carboxyalkyldipeptides and pharmaceutical compositions
NZ214048A (en) Cephalosporins and pharmaceutical compositions
NZ216438A (en) Steroid-pyrazoles and pharmaceutical compositions